Navigation Links
BioMS Medical announces third quarter 2007 results
Date:11/14/2007

Toronto Stock Exchange Symbol: MS

EDMONTON, Nov. 14 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the third quarter, ended September 30, 2007.

"During the quarter, we continued to maintain momentum towards the commercialization of our lead drug, MBP8298, for the treatment of multiple sclerosis," said Kevin Giese, President and CEO of BioMS Medical.

Third Quarter 2007 Highlights:

- The independent Data Safety Monitoring Board (DSMB) for MINDSET-01,

the Company's on-going phase II trial of MBP8298 for relapsing-

remitting MS, completed a safety analysis and recommended that the

trial continue as per protocol. This double blind phase of this trial

is expected to complete in the second half of 2008.

- Subsequent to the end of the quarter,

- Two posters presented at the 23rd Congress of the European

Committee for Treatment and Research in Multiple Sclerosis

(ECTRIMS) in Prague, Czech Republic, in respect of the phase

III MAESTRO-01 secondary progressive MS (SPMS) study, showed

that over 70% of the screened patients had the drug's target

HLA DR2 and/or DR4 responder genes, and that an interim

analysis showed no significant safety concerns with the drug.

An interim safety and efficacy analysis for MAESTRO-01 is

planned for mid-2008.

- The Company announced that the U.S. pivotal phase III SPMS

trial, MAESTRO-03, is on track for full enrollment in 2008, and

completed enrollment of the first 133 patients who will form

the basis of an interim analysis that is expected in 2009.

Financial Results

The consolidated net loss for the three months ended
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
10. ATS Medical Expands Open Pivot Heart Valve Offerings
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...tCall/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) tod...structuring plans to further reduce its cash burn ...n exploring strategic alternatives that may,includ...on with this,process, the Company has also complet...and has determined that it is in the best interest...
(Date:7/3/2008)...FirstCall/ -- Huifeng,Bio-Pharmaceutical Technolog...loper and producer of plant extracts and pharmaceu...raceutical and food production in China,announced...vailable via,Standard & Poor,s Market Access Progr...es subscribing publicly traded companies to have t...
(Date:7/2/2008)...e immediately, SpectraCell,Laboratories now measur...g,its proprietary FIA(TM) (Functional Intracellula...ian to diagnose specific vitamin and mineral,defic...pear. The demand for,testing Vitamin C levels in p...esents an important addition to their existing pan...
(Date:7/2/2008)...of Pharmacy Incorporates, Med-eMonitor(TM) and M... Curriculum, ROCKVILLE... Holdings,Inc. (OTC Bulletin Board: IFMX) is plea...School of Pharmacy has successfully incorporated,I...to its teaching,curriculum, to teach the role of t...
Breaking Biology Technology:Vasogen Provides Corporate Update 2Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2SpectraCell Laboratories Now Measures Vitamin C 2Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedix's Med-eXpert(TM) System 2Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedix's Med-eXpert(TM) System 3Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedix's Med-eXpert(TM) System 4
...ere am I? ,What is this? ,Why did they call it tha...s to your companys Web site had better not have to...cording to ,Patrick Bieser, founder of Northwood... self-explanatory, Bieser said. They (users) shoul...November meeting of eInnovate, the networking grou...
... technology job seekers. Its also for all Midweste...ard on job seekers here? Because so many of us are...More than that, it,s because theres so much to say...ng. So many things to know. So many angles to try....to scotch your chances for your next great job, so...
...otonics announced today that TDS Metrocom selected...ngth platforms to deliver new Ethernet services to...ervice, called MegaDATA and GigaDATA will offer ma...le applications. , ,According to Ben Goth, manager...des a managed Ethernet service to meet the market ...
...U.S. Patent and Trade Office issued U.S. Patent No...olymerase and Uses Thereof to the Wisconsin Alumn...cy of the University of Wisconsin-Madison. ConjuG...llectual property invented by its co-founder Richa... research group, which included ConjuGon scientist...
Other Biology Technology:How Usable is Your Web Site? 2Its Your Midwest Technology Wake, Stupid 2Its Your Midwest Technology Wake, Stupid 3
(Date:7/2/2008)...a, July 2, 2008 Volunteers representing the Juven...RF), the American Diabetes Association (ADA) and t...t Senator Byron Dorgan with the 2008 Congressional...the Special Diabetes Program (SDP) in Congress. T...i Room at the Hilton Garden Inn in Grand Forks. ...
(Date:7/2/2008)...ble in Spanish . , Most of the functions perfo...een proteins, which recognise their binding partne...rface. There are many kinds of interactions; howev...tive of structural biology are those which are tra...rs through a large section of the protein surface-...
(Date:7/2/2008)...rcial flower and plant growers know all too well t...wering the value and deterring healthy growth of p...mmercial nursery owners resort to the expensive pr...Some growers use herbicides, but efficacy of herbi...pecies produced in nurseries, and many herbicides ...
(Date:7/1/2008)... from Kettering Police Department Streamlines ...LL, N.J., July 1 /PRNewswire-FirstCall/ -- BIO-key... leader in finger-based biometric,identification a... from the,Kettering, Ohio Police Department for Mo...ed services. With this award, officers on patrol w...
Breaking Biology News(10 mins):Sen. Byron Dorgan to be honored 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Ethanol byproduct produces green results 2Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software 2Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software 3Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference 427 1Theater Classes Help Docs Bedside Manners 744 1Theater Classes Help Docs Bedside Manners 744 2Theater Classes Help Docs Bedside Manners 744 3AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium 426 1AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium 426 2Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 1Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 2Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 3
... team of scientists has used gene therapy in two s...ormal movements in monkeys and rats with a drug-in..., detailed online in the scientific publications B...describes one strategy to halt Parkinson,s disease...vastating side effects that occur when treating th...
... laboratory work studying how animals evolve, rese...ull out the fishing net and go learn how their the...nford University School of Medicine study publishe...is more predictable than lab experiments suggest. ...k, nature took advantage of the same genetic trick...
...based at Massachusetts General Hospital (MGH) has ...f RNA interference (RNAi), a powerful new research... They used the RNAi process itself to find new gen...m, which someday may help to fight human disease. ...is receiving early online release on the Science E...
... lives in the human gut adaptively shifts more tha...ost,s diet changes from sugar to complex carbohydr...he bacterial species to survive rapidly changing n...ctions and stability of the gut,s highly complex m...ington University School of Medicine in St. Louis....
Other Biology News:Gene Therapy For Parkinson's Disease Moves Forward In Animals 2Gene Therapy For Parkinson's Disease Moves Forward In Animals 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 4Same mutation aided evolution in many fish species, Stanford study finds 2Same mutation aided evolution in many fish species, Stanford study finds 3Scientists identify genetic pathways essential to RNA interference 2Highly adaptable genome in gut bacterium key to intestinal health 2Highly adaptable genome in gut bacterium key to intestinal health 3
The Beacon 2000 Fluorescence Polarization System is an ideal tool for basic research and assay development. Standard Beacon 2000 System: The Standard Beacon 2000 System uses a quartz-halogen lamp th
The bench-top stand comfortably holds up to 6 Finnpipette Digital single- and multichannel pipettes. The crossbars are made of a grippy material to keep the pipettes firmly in place. Individual shelf
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni
...serine/threonine phosphatase isolated from human r...of 60kDa (A) and 36kDa (C) subunits. It has the ab...ylase kinase. With its 3638kDa catalytic subunit, ...lay a regulatory role in DNA replication, transcri...
Biology Products: